FDA Approves PENBRAYA™, the First and Only Vaccine for the Prevention of the Five Most Common Serogroups Causing Meningococcal Disease in Adolescents
PENBRAYA™ provides the broadest serogroup coverage of any meningococcal vaccine available in the U.S. and has the potential to help simplify complex vaccination schedule in the U.S. The...
Source: marketscreener.com